☰

Julie D. Griffin, Ph.D. - Publications

Affiliations: 
University of Texas at Austin, Austin, Texas, U.S.A. 
Area:
development, aging
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 De La Puente P, Weisberg E, Nonami A, Luderer MJ, Stone RM, Melo JV, Griffin JD, Azab AK. Integrin-Linked Kinase a Novel Therapeutic Target for Acute and Chronic Myeloid Leukemia Blood. 126: 3694-3694. DOI: 10.1182/BLOOD.V126.23.3694.3694  0.305
2013 Weisberg E, Liu Q, Zhang X, Nelson E, Sattler M, Liu F, Nicolais M, Zhang J, Mitsiades C, Smith RW, Stone R, Galinsky I, Nonami A, Griffin JD, Gray N. Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells. Plos One. 8: e56473. PMID 23437141 DOI: 10.1371/Journal.Pone.0056473  0.3
2008 Weisberg E, Banerji L, Wright RD, Barrett R, Ray A, Moreno D, Catley L, Jiang J, Hall-Meyers E, Sauveur-Michel M, Stone R, Galinsky I, Fox E, Kung AL, Griffin JD. Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells. Blood. 111: 3723-34. PMID 18184863 DOI: 10.1182/blood-2007-09-114454  0.305
2005 Sattler M, Walz C, Crowley BJ, Gramlich JL, King KL, Podar K, Griffin JD. The Jak2V617F Oncogene Associated with Polycythemia Vera Regulates G1/S-Phase Transition. Blood. 106: 3510-3510. DOI: 10.1182/BLOOD.V106.11.3510.3510  0.311
2004 Sattler M, Babendreier E, Chu SC, Gramlich JL, Podar K, Griffin JD. Pim Kinases Mediate Viability Signals Downstream of the Tyrosine Kinase Oncogenes BCR-ABL and FLT3-ITD. Blood. 104: 557-557. DOI: 10.1182/BLOOD.V104.11.557.557  0.303
2004 Chen J, Lee BH, Williams IR, Kutok JL, Duclos N, Cohen S, Adelsperger J, Okabe R, Coburn A, Moore S, Huntly BJ, Mitsiades CS, Anderson KC, Griffin JD, Fabbro D, et al. PKC412 Effectively Inhibits Constitutively Activated FGFR3 Mutants in Murine Leukemia Models and t(4;14) Myeloma Cell Lines. Blood. 104: 2448-2448. DOI: 10.1182/BLOOD.V104.11.2448.2448  0.307
2002 Gary Gilliland D, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia Blood. 100: 1532-1542. PMID 12176867 DOI: 10.1182/blood-2002-02-0492  0.306
1996 Hallek M, Danhauser-Riedl S, Herbst R, Warmuth M, Winkler A, Kolb HJ, Druker B, Griffin JD, Emmerich B, Ullrich A. Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells British Journal of Haematology. 94: 5-16. PMID 8757502 DOI: 10.1046/J.1365-2141.1996.6102053.X  0.31
Show low-probability matches.